Calydon Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $17.7M
Latest Deal Amount

Calydon General Information

Description

Developer of therapeutic products for cancer. The company is focused on the development and commercialization of innovative therapeutic products for cancer based on gene therapy technologies.

Contact Information

Website
www.calydon.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Primary Office
  • 1331 Hillview Drive
  • Menlo Park, CA 94025
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Calydon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 05-Sep-2001 $17.7M 000.00 000.00 Completed Clinical Trials - Phase 2
2. Early Stage VC 11-Dec-1997 000.00 000.00 Completed Product Development
1. Early Stage VC $3.8M $3.8M Completed
To view Calydon’s complete valuation and funding history, request access »

Calydon Patents

Calydon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-3292499-A Prostate cancer drug screening Withdrawn 12-Feb-1998 0000000000
EP-0844888-A4 Tissue specific viral vectors Granted 27-Jun-1995 000000000 0
ES-2242196-T3 Adenoviral vectors understanding an "element response". Expired - Lifetime 27-Jun-1995 000000000
JP-4117347-B2 Tissue-specific virus vector Expired - Fee Related 27-Jun-1995 000000000
EP-0844888-B1 Adenovirus vectors comprising a prostate specific antigen (psa) response element Expired - Lifetime 27-Jun-1995 C12N15/86
To view Calydon’s complete patent history, request access »

Calydon Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AmBex Venture Partners Venture Capital Minority 000 0000 000000 0
Genesis Merchant Partners Lender/Debt Provider Minority 000 0000 000000 0
Perseus (Bethesda) PE/Buyout Minority 000 0000 000000 0
Sequoia Capital Venture Capital Minority 000 0000 000000 0
To view Calydon’s complete investors history, request access »